Main Page
From GxPlex
This wiki is a structured reference database for regulatory documents in the medical devices, in vitro diagnostics, and pharmaceutical sectors. Each document is stored with standardized metadata (scope, validity status, region, official source) and linked to individual reference pages for key articles, annexes, and provisions.
The database currently covers regulations, directives, and guidelines in the MD, IVD, HM, GMP, PV, and NIS scopes. Cross-references between equivalent provisions in different regulations are maintained explicitly.
Structured queries are available on the Document Index. Use GxPlex Search for filter-based browsing, or Special:Ask for custom SMW queries.
All registered users can contribute. New pages require reviewer approval before becoming publicly visible.
Browse |
By category |
Contribute |
Recent documents
| Document name | Scope | Region | Status | |
|---|---|---|---|---|
| N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 | (STROBE)statement: guidelines for reporting observational studies | INS | N.A. | N.A. |
| EU 2011/C 172/01 - CT-3 11-Jun-2011 | 2011/C 172/01 - CT-3 | G | EU | Current |
| USA 21 CFR Part 11 09-Apr-2025 | 21 CFR Part 11 | G | USA | Current |
| USA 21 CFR Part 312 09-Apr-2025 | 21 CFR Part 312 | HM | USA | Current |
| USA 21 CFR Part 314 09-Apr-2025 | 21 CFR Part 314 | HM | USA | Current |
| USA 21 CFR Part 320 09-Apr-2025 | 21 CFR Part 320 | HM | USA | Current |
| USA 21 CFR Part 50 09-Apr-2025 | 21 CFR Part 50 | G | USA | Current |
| USA 21 CFR Part 54 09-Apr-2025 | 21 CFR Part 54 | G | USA | Current |
| USA 21 CFR Part 56 09-Apr-2025 | 21 CFR Part 56 | G | USA | Current |
| USA 21 CFR Part 809 06-May-2024 | 21 CFR Part 809 | G | USA | Current |
| ... further results | ||||
